Halozyme Therapeutics (HALO)
NASDAQ:HALO

Halozyme Similar Stocks

671 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Halozyme
$7.71B
38.43
77.99%
5 Buy
0 Hold
0 Sell
Strong Buy
$58.60
premium
premium
Incyte
$17.31B
20.25
22.64%
3 Buy
6 Hold
1 Sell
Hold
$84.00
premium
premium
United Therapeutics
$12.35B
19.04
47.98%
8 Buy
1 Hold
0 Sell
Strong Buy
$296.50
premium
premium
Sarepta Therapeutics
$10.28B
-14.96
49.42%
12 Buy
3 Hold
0 Sell
Strong Buy
$143.64
premium
premium
Legend Biotech
$8.12B
-21.51
3.35%
6 Buy
1 Hold
0 Sell
Strong Buy
$71.75
premium
premium
Neurocrine
$11.70B
218.84
57.56%
9 Buy
9 Hold
1 Sell
Moderate Buy
$126.72
premium
premium

Performance Comparison

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis